Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Capital Reinvestment Ratio

Latest as of March 2025: 0.00x

Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($924.90K) in capital expenditures ($3.00). See Translational Development Acquisition Co (TDAC) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$924.90K

USD

Capital Expenditures

$3.00

USD

Data as of

Mar 2025

Most recent filing

Annual Capital Reinvestment Ratio for Translational Development Acquisition Corp. Ordinary Shares (None–None)

Year-by-year Capital Reinvestment Ratio for Translational Development Acquisition Corp. Ordinary Shares from None to None. For live market cap and broader valuation context, see Translational Development Acquisition Co (TDAC) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow